Trastuzumab plus chemotherapy based on the accurate HER2-positivity testing for patients with advanced gastric cancer.
Tetsuya Kusumoto
No relevant relationships to disclose
Yasue Kimura
No relevant relationships to disclose
Norifumi Tsutsumi
No relevant relationships to disclose
Mitsuhiko Ohta
No relevant relationships to disclose
Masahiko Sugiyama
No relevant relationships to disclose
Eiji Kusumoto
No relevant relationships to disclose
Yoshihisa Sakaguchi
No relevant relationships to disclose
Koji Ikejiri
No relevant relationships to disclose
Hiroshi Saeki
No relevant relationships to disclose
Eiji Oki
No relevant relationships to disclose
Yoshihiko Maehara
No relevant relationships to disclose